极速赛车

BioNTech's Acquisition Of CureVac Ends COVID Vax Case

By Elliot Weld ( August 7, 2025, 7:16 PM EDT) -- CureVac's case alleging Pfizer and BioNTech infringed patents related to messenger RNA technology is set to be dismissed after BioNTech announced in June that it would be acquiring CureVac, canceling what would have been the first-ever trial over COVID-19 vaccine patents in the U.S....

极速赛车 is on it, so you are, too.

A 极速赛车 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A 极速赛车 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience 极速赛车 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login